A combination of dipotent Talvey® and Tecvayli® investigations in class demonstrates a deep, durable response in severely pretreated multiple myeloma patients with extramedullary disease
A combination of dipotent Talvey® and Tecvayli® investigations in class demonstrates a deep, durable response in severely pretreated multiple myeloma patients with extramedullary disease